Investing News NetworkYour trusted source for investing success

major depressive disorder

ACADIA Pharmaceuticals Announces Positive Top-line Results from Phase 2 CLARITY Trial

Sage Announces Pivotal Phase 3 Trial Status for SAGE-217 in Major Depressive Disorder and Postpartum Depression based on FDA Breakthrough Therapy Meetin

Landmark Study Shows GeneSight Test Led to Significant Improvement in Mental Health Outcomes for Patients with Major Depressive Disorder

Minerva Neurosciences Screens First Patient in Phase 2b Trial of MIN-117 to Treat Major Depressive Disorder

VistaGen Therapeutics Initiates Phase 2 Study of AV-101 for Major Depressive Disorder

Cerecor Sells Rights of Opioid Receptor to Janssen

VistaGen Seeks to Advanced the Development of AV-101

Cerecor Reports New Data from CERC-501 Trial

Response to ASX Price and Volume Query

NorthStar Gaming Reports Second Quarter 2025 Results

GMV Minerals Inc. Announces Updated PEA Results at Mexican Hat Gold Project in S.E. Arizona

Sranan Gold Initiates Diamond Core Drilling Program on the Randy Trend at the Tapanahony Project in Suriname

Silver47 Unveils Multiple Premier Exploration Targets with Strong Discovery Potential Across the Red Mountain Project, Alaska

Brunswick Exploration

Asra Minerals

North Shore Uranium

Skyharbour Resources

Westport

Piche Resources

MARKETS

COMMODITIES

CURRENCIES